Epioxa, the first FDA-approved epithelium-on cross-linking procedure, is now commercially available, according to a press release from Glaukos.

GLP-1 receptor agonist use in adults with concurrent type 2 diabetes and obesity was associated with increased risk for osteoporosis, gout and osteomalacia vs. a matched control group, according to ...

Roflumilast cream 0.05% was well-tolerated and effective for the long-term treatment of mild to moderate atopic dermatitis in ...

With the singular exception of punctal or canalicular occlusion, when we are talking about in-office dry eye disease ...

Waist circumference, not BMI, was tied to increased risk for adiposity-related heart failure, and the association was ...

Adults with diabetes had an elevated risk for dementia, with a higher risk among those with type 1 compared with type 2 ...

Finerenone demonstrated safety and reduced albuminuria for patients with chronic kidney disease, type 2 diabetes and a ...

The FDA has approved the first medication for cholestatic pruritus in adult patients with primary biliary cholangitis.The approval of linerixibat (Lynavoy, GSK) — an ileal bile acid transporter ...

Ndemex, a formulation of tea tree oil designed to promote ocular hygiene, is now available.It can be used once daily to help “support good ocular health in the fight against blepharitis and other ...

The likelihood that a person with early-stage non-small cell lung cancer will receive curative treatment still varies considerably by race, even though 3 decades have passed since researchers first ...

Finding ways that AI best fits into clinical practice while learning how accurate and useful it can be, especially for patients, could help clinicians trust it more in their daily workflow.“I do think ...

The FDA approved a higher 7.2 mg dose of injectable semaglutide for adults with overweight and obesity, Novo Nordisk announced. Once-weekly injectable semaglutide 7.2 mg (Wegovy HD, Novo Nordisk) ...